• Prof. Snehanshu Basu

In today’s challenging and competitive environment, the matter of designing appropriate strategies for managing risks in accomplishing the wealth maximization objective of pharmaceutical sector is of utmost importance. Considering the stiff competition that exists in the contemporary corporate world, understanding analyzing and measuring business risk are immensely important to the pharmaceutical sector that belongs to the corporate world in order to investigate managerial efficiency and excellence. The pattern of business risk associated with the companies in the Indian pharmaceutical sector has witnessed notable changes. In this backdrop, the present study seeks to analyze the business risk in the Indian pharmaceutical sector.

Business Risk, Return.

"COMPANY-SPECIFIC COMPONENTS OF BUSINESS RISK OF SELECTED PHARMACEUTICAL COMPANIES IN INDIA:", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 7, page no.795-811, July-2020, Available :http://www.jetir.org/papers/JETIR2007400.pdf

"COMPANY-SPECIFIC COMPONENTS OF BUSINESS RISK OF SELECTED PHARMACEUTICAL COMPANIES IN INDIA:", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 7, page no. pp795-811, July-2020, Available at : http://www.jetir.org/papers/JETIR2007400.pdf